Your browser doesn't support javascript.
loading
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
Flippot, Ronan; Dalban, Cécile; Laguerre, Brigitte; Borchiellini, Delphine; Gravis, Gwénaelle; Négrier, Sylvie; Chevreau, Christine; Joly, Florence; Geoffrois, Lionnel; Ladoire, Sylvain; Mahammedi, Hakim; Rolland, Frédéric; Gross-Goupil, Marine; Deluche, Elise; Priou, Frank; Laramas, Mathieu; Barthélémy, Philippe; Narciso, Bérengère; Houedé, Nadine; Culine, Stéphane; Oudard, Stéphane; Chenot, Marina; Tantot, Florence; Chabaud, Sylvie; Escudier, Bernard; Albiges, Laurence.
Afiliação
  • Flippot R; 1Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.
  • Dalban C; 2Centre Léon Berard, Lyon, France.
  • Laguerre B; 3Centre Eugene Marquis, Rennes, France.
  • Borchiellini D; 4Centre Antoine Lacassagne, Université Côte d'Azur, Nice, France.
  • Gravis G; 5Institut Paoli Calmettes, Marseille, France.
  • Négrier S; 2Centre Léon Berard, Lyon, France.
  • Chevreau C; 6Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.
  • Joly F; 7Centre François Baclesse, Caen, France.
  • Geoffrois L; 8Institut de Cancérologie de Lorraine, Vandoeuvre-lès-Nancy, France.
  • Ladoire S; 9Centre Georges François Leclerc, Dijon, France.
  • Mahammedi H; 10Centre Jean Perrin, Clermont-Ferrand, France.
  • Rolland F; 11Centre René Gauducheau, Saint Herblain, France.
  • Gross-Goupil M; 12Bordeaux University Hospital, Bordeaux, France.
  • Deluche E; 13Limoges University Hospital, Limoges, France.
  • Priou F; 14Centre Hospitalier de Vendée, La Roche sur Yon, France.
  • Laramas M; 15Alpes University Hospital, Grenoble, France.
  • Barthélémy P; 16Strasbourg University Hospital, Strasbourg, France.
  • Narciso B; 17Tours University Hospital, Tours, France.
  • Houedé N; 18Nimes University Hospital, Nimes, France.
  • Culine S; 19Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Oudard S; 20Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Chenot M; 21Université Montpellier, Montpellier, France.
  • Tantot F; 22GETUG Group, Unicancer, Paris, France.
  • Chabaud S; 2Centre Léon Berard, Lyon, France.
  • Escudier B; 1Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.
  • Albiges L; 1Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.
J Clin Oncol ; 37(23): 2008-2016, 2019 08 10.
Article em En | MEDLINE | ID: mdl-31194611
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma de Células Renais / Antineoplásicos Imunológicos / Nivolumabe Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma de Células Renais / Antineoplásicos Imunológicos / Nivolumabe Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: França